First Time Loading...

Yield10 Bioscience Inc
NASDAQ:YTEN

Watchlist Manager
Yield10 Bioscience Inc Logo
Yield10 Bioscience Inc
NASDAQ:YTEN
Watchlist
Price: 2.236 USD -5.65% Market Closed
Updated: May 17, 2024

Yield10 Bioscience Inc
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Yield10 Bioscience Inc
Accounts Payable Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
Yield10 Bioscience Inc
NASDAQ:YTEN
Accounts Payable
$1.2m
CAGR 3-Years
129%
CAGR 5-Years
64%
CAGR 10-Years
7%
Abbvie Inc
NYSE:ABBV
Accounts Payable
$30.7B
CAGR 3-Years
15%
CAGR 5-Years
21%
CAGR 10-Years
17%
Gilead Sciences Inc
NASDAQ:GILD
Accounts Payable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Accounts Payable
$1.6B
CAGR 3-Years
5%
CAGR 5-Years
8%
CAGR 10-Years
6%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Accounts Payable
$3.4B
CAGR 3-Years
180%
CAGR 5-Years
98%
CAGR 10-Years
53%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Accounts Payable
$671.3m
CAGR 3-Years
7%
CAGR 5-Years
23%
CAGR 10-Years
35%

See Also

What is Yield10 Bioscience Inc's Accounts Payable?
Accounts Payable
1.2m USD

Based on the financial report for Dec 31, 2023, Yield10 Bioscience Inc's Accounts Payable amounts to 1.2m USD.

What is Yield10 Bioscience Inc's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
7%

Over the last year, the Accounts Payable growth was 1 102%. The average annual Accounts Payable growth rates for Yield10 Bioscience Inc have been 129% over the past three years , 64% over the past five years , and 7% over the past ten years .